A bdominal aortic aneurysm (AAA) is a disease of the cardiovascular system that is characterized by aortic dilation that exceeds the normal aortic diameter by >50%. Age, atherosclerosis, hypertension, male sex, and smoking are major AAA risk factors. 1, 2 In epidemiological studies, the sex difference shows a male dominance with a ratio of 4:1. In inflammatory AAA, the male sex is even a stronger risk factor resulting in male dominance of AAA ranging from 6:1 to 30:1.
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Another group suggested that dihydrotestosterone treatment could inhibit TNF-α-induced inflammatory cytokines and this effect was reversed by antiandrogen treatment. 11 Androgen effects on SMCs have been well characterized about their behaviors, apoptosis, and migration in AAA development. 12 Testosterone treatment could induce vascular SMCs migration through NADPH oxidase and c-Src-dependent pathways. 13 Testosterone also induces apoptosis in vascular SMCs. 14 Together, all evidence indicates that AR exists in those cell types and is involved in the cellular behaviors of those cells.
In this study, we investigated the role of AR in angiotensin II (Ang II)-induced AAA formation as the reason for the male sex predominance, in whole body general AR knockout (GARKO) mice. Furthermore, we determined the contribution of specific cell types using macrophage-specific, SMCspecific, and endothelial cell-specific AR knockout mice. The influence of interleukin-1α (IL-1α), transforming growth factor-β1 (TGF-β1), infiltrating macrophages, matrix metallopeptidases (MMPs) production, and fibrosis were also determined. Together, these results indicate the importance of cell type-specific AR expression in the sex-dependent risk for AAA development.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

AR Deficiency Blocks Ang II-Induced AAA Formation In Vivo
To investigate whether AR influences AAA initiation and progression, we established GARKO mice in the apolipoprotein E null (apoE −/− ) background (GARKO-apoE −/− ). Mating strategy and genotyping results are shown in Figure 1A and 1B. There were marked decreases of testosterone and dihydrotestosterone levels in GARKO-apoE −/− mice compared with wild-type apoE −/− (WT-apoE −/− ) mice ( Figure S1A and S1B in the online-only Data Supplement). Ang II was used to induce AAA formation for 4 weeks in GARKO-apoE −/− and WT-apoE −/− mice. Consistent with previous reports, we found that 4 weeks of Ang II infusion promoted AAA formation in apoE −/− mice. 4 Ang II infusion significantly increased blood pressure in apoE −/− mice ( Figure S1C and S1D), but no gross differences in aortic morphology were observed between saline-infused WT-apoE −/− and GARKO-apoE −/− mice ( Figure  1C) . Surprisingly, we found that none of the GARKO-apoE −/− mice developed AAAs after Ang II induction ( Figure 1D ). In contrast, 82% of WT-apoE −/− mice developed AAA ( Figure 1C  and 1D ). The maximal aortic diameter outcome also exhibited significant reduction in Ang II-treated GARKO-apoE −/− mice compared with Ang II-treated WT-apoE −/− mice ( Figure 1E ). These results suggest that AR plays an essential role in Ang II-induced AAA formation.
Macrophage infiltration is one of the critical events involved in AAA development. 2 We next investigated whether differences could be observed in macrophage infiltration. We found that Ang II infusion promoted macrophage infiltration and elastic fiber fragmentation/degeneration as indicated with arrowheads (the left side of arrowheads with pink color is the aneurysmal tissue) in WT-apoE −/− mice, but not in GARKOapoE −/− mice ( Figure 1F and 1G) suggesting that AR may promote AAA formation via modulating infiltrating macrophages and aortic wall degeneration, which are 2 important factors promoting AAA development. 15, 16 Vascular endothelial cells and vascular SMCs are the major types of cells contributing to the maintenance of integrity in the aortic wall 17 and our observations showing the importance of AR in these processes is of great significance.
AR in Macrophages and SMCs Promotes AAA Formation but AR in Endothelial Cells Has No Impact on AAA Formation
Because macrophages, vascular endothelial cells, and vascular SMCs could contribute to AR-dependent AAA formation, we used cell type-specific knockout strategies via the Cre-loxP recombination system to develop cell-specific AR knockout in endothelial cells, macrophages, and SMCs to determine how AR in these specific cell types contributes to AAA formation. As shown in Figure S2 , we developed macrophage, SMC, and endothelial cell AR-specific knockout mice by breeding specific cell driven Cre mice (lysozyme Cre mice for monocyte/macrophage, transgelin Cre mice for SMCs, and vascular endothelial cadherin Cre mice for endothelial cells) with the apoE null mice. We then used these resultant mice to cross with floxed AR/AR-apoE −/− mice to generate macrophage AR-specific knockout mice in apoE null background (named MARKO-apoE −/− ; Figure  S2A and S2D), SMC-specific AR knockout mice with apoE knockout background (named SARKO-apoE −/− ; Figure  S2B and S2D) and endothelial cell-specific AR knockout mice on apoE −/− background (named EARKO-apoE −/− ; Figure S2C and S2D). The cell-specific ARKO effects have been determined in our previous study 18 and the genotyping data indicate that these cell-specific ARKO mice used in this study have ARKO in aortic tissue ( Figure S2D ). EARKO-apoE −/− , MARKO-apoE −/− , SARKO-apoE −/− , and WT-apoE −/− mice were then treated with Ang II to induce AAA formation. Consistent with previous results, we found that WT-apoE −/− mice infused with Ang II developed a significant increase in the size of the aorta, although there were significant reductions of AAA incidence and maximal aortic diameter in MARKO-apoE −/− mice (20% AAA incidence; Figure 2A ) and SARKO-apoE −/− mice (12.5% AAA incidence; Figure 2B ). However, endothelial cell-specific AR knockout did not affect AAA development ( Figure 2C ). Furthermore, macrophage infiltration was attenuated in MARKO-apoE −/− and SARKO-apoE −/− mice but not in EARKO-apoE −/− mice ( Figure S2E ).
In summary, using a cell type-specific ARKO strategy to dissect AR functions of specific cell types in AAA formation, we found that AR in macrophages and SMCs, but not endothelial cells, mediates AAA formation.
contribute to androgen/AR signaling-mediated AAA progression. 19 We also found that dihydrotestosterone could promote AT1R expression but knockout of AR could not suppress AT1R expression ( Figure S3 ). Therefore, we decided to further dissect these complicated mechanisms via investigating the inflammatory pathways because the inflammatory response is one of the underlying mechanisms contributing to AAA development. 2 To understand the risk posed by the male sex, we used aortic tissues of GARKO-apoE −/− versus WT-apoE −/− mice and performed a focused quantitative polymerase chain reaction array to screen for inflammatory cytokines/ chemokines that are modulated by AR in AAA formation. Aortic morphology, blood pressure, and MMP9 expression were measured to confirm that Ang II-induced AAAs were as previously described. 15 We found aortic morphology was consistent with previous observations and Ang II treatments increased blood pressures in WT-apoE −/− and GARKO-apoE −/− mice compared with saline treatments (Figure S1C and S1D; Figure 4A ). Upregulation of MMP9 expression occurred in WT-apoE −/− mice, but not in GARKO-apoE −/− mice after Ang II induction ( Figure S4B ). Array analysis revealed that several inflammation-associated genes, including CCL4, CCL9, IL-1α, TNF-α, and TGF-β1 were significantly suppressed in aortic tissues of Ang II-treated GARKO-apoE −/− mice compared with Ang II-treated WT-apoE −/− mice (Table S1 ). To validate the array analysis, we measured IL-1α expression in aortic tissues of these mice as evidence indicates that IL-1 is a major inflammatory cytokine elevated in patients with AAA. 
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Ang II treatment promoted IL-1α expression in WT-apoE −/− mice compared with vehicle control ( Figure 3A) ; however, this enhancement was reduced when AR was knocked out ( Figure 3B and 3C). IL-1 has been shown to enhance macrophage infiltration and stimulate MMPs in macrophages and other cell types. 21, 22 Macrophage chemo-attractant protein 1 (MCP-1) is a crucial downstream target of IL-1α. We therefore determined how AR modulates this signaling cascade. Loss of AR significantly inhibited MCP-1 expression in Ang II-infused apoE −/− mice ( Figure 3D ). Similarly, MMP2 and MMP9 expression levels were dramatically increased in Ang II-induced apoE −/− mice, whereas knockout of AR inhibited MMP2 and MMP9 expression at the mRNA and protein levels ( Figure 3E-3H) . Consistently, knockdown of AR in THP-1 cells, human monocytes/macrophages, also inhibited those inflammatory cytokines and expression levels of MMPs ( Figure 3I ). These results suggest that AR modulates expression of IL-1α and key downstream target proteins.
To further dissect the molecular mechanism by which AR modulates IL-1α expression, we examined whether AR directly binds to the IL-1α promoter region and regulates its transcription. Most identified androgen responsive elements are located within the promoter region of AR target genes with >9 bases matching with consensus androgen responsive element-binding motif. 23 By scanning, we identified many potential androgen responsive elements in the IL-1α promoter region and confirmed that AR could bind to one of these regions ( Figure 3J , bottom) and promoted IL-1α transactivation ( Figure 3J , top). These results suggest that AR modulates AAA formation by elevating IL-1α expression, which in turn increases expression levels of MCP-1 and MMPs.
Restoration of IL-1α Partially Reverses the AR Knockout Effects on Promoting AAA Formation
To test whether MMPs activation is a consequence of increased IL-1α expression by AR, we used an in vitro culture system using THP-1 cells to determine the consequent molecular mechanism events. Knockdown of AR resulted in suppressed MMP2 and MMP9 expression ( Figure 4A 
AR Modulates AAA Formation Through Stimulating Fibrosis via TGF-β1 Signaling
Fibrosis of the adjacent retroperitoneum is a major characteristic in inflammatory aneurysms, 24 and TGF-β1 is known to play a key role in fibrosis development. 25 Therefore, we next addressed whether AR might modulate fibrosis to exacerbate AAA. Consistent with previous reports, Ang II-induced AAA has elevated TGF-β1 expression in WT-apoE −/− mice compared with saline-infused WT-apoE −/− mice (data not shown). 26 Interestingly, deletion of AR suppressed TGF-β1 expression in Ang II-induced apoE −/− mice compared with WT-apoE −/− mice ( Figure 5A and 5B, arrows). To demonstrate the involvement of TGF-β1, we examined mothers against decapentaplegic homolog 3 (SMAD3), which initiates intracellular signaling by TGF-β1-dependent phosphorylation and the result showed that AR deletion inhibited pSMAD3 in Ang II-induced AAA mouse model ( Figure 5C ). Collagen levels were also examined to demarcate the fibrotic areas of Figure 5D ). Mechanism dissection revealed that AR could bind to the putative androgen responsive element sequence located from −3132 to −3118 in the TGF-β1 promoter region and AR expression is a positive regulator for TGF-β1 transcriptional regulation ( Figure 5E and 5F).
To determine whether TGF-β1 is critical in AR-mediated AAA formation, we investigated whether in vivo restoration of TGF-β1 could reverse the protective effect of AR deletion on AAA formation. Green fluorescence protein-labeled TGF-β1 was delivered into Ang II-infused GARKO-apoE −/− mice and AAA formation was monitored. TGF-β1 levels and green fluorescence protein expression confirmed successful delivery of TGF-β1 into the aortic area (Figure 5G and 5H; S5B). Restoration of TGF-β1 partially reversed the suppressive effect of AR knockout on AAA formation in GARKO-apoE −/− mice as judged by morphology, disease incidence, and maximal abdominal aortic diameter ( Figure 5I-5K) . Increased collagen staining indicates increased fibrotic area in TGF-β1-delivered GARKO-apoE −/− mice ( Figure 5L ). Taken together, we conclude that AR promotes AAA formation partially through increasing fibrosis via upregulation of TGF-β1 signaling.
Targeting AR With the AR Degradation Enhancer ASC-J9 Effectively Blocks AAA Formation
Our studies of ARKO mice indicate that AR is a critical factor in Ang II-induced AAA formation, suggesting the possibility that targeting AR might be therapeutically beneficial for patients with AAA. ASC-J9, an AR degradation enhancer, has been well characterized with better efficacy but little side effects on fertility ( Figure S6 ) in treating AR-related diseases, such as spinal and bulbar muscular atrophy. 27 To test whether ASC-J9 might have therapeutic effects in treating AAA, we treated Ang II-induced AAA apoE −/− mice with this compound and compared results with mice receiving vehicle only. ASC-J9 treatment significantly suppressed AAA incidence and reduced maximal abdominal aortic diameter in Ang IItreated apoE −/− mice compared with control ( Figure 6A-6C ). In addition, ASC-J9 reduced AR, IL-1α, and TGF-β1 expression levels ( Figure 6D-6F) . Expression of MMP2 and MMP9, downstream of IL-1α, was significantly lower in ASC-J9-treated mice than in control ( Figure 6G and 6H) . Furthermore, ASC-J9 treatment reduced fibrosis in Ang II-treated apoE −/− mice ( Figure 6I ). These findings suggest that targeting AR with ASC-J9 is a novel therapeutic approach for treatment of AAA.
Discussion
In this study, we demonstrated that AR plays a proinflammatory role in AAA development. We first found that AR is required for Ang II induction of AAA. Using the Cre-loxP recombination strategy, we were able to knockout AR specifically in macrophages, SMCs, and endothelial cells, and showed the importance of AR in macrophages and SMCs in AAA progression. Our inflammatory cytokine analysis found that inflammatory cytokines were significantly suppressed when AR was deleted. One of these inflammatory cytokines, IL-1α, has been linked to inflammatory AAA formation.
2,20,28
When we restored IL-1α in GARKO-apoE −/− mice in vivo, knockout of AR effects on AAA development were significantly reversed, suggesting that AR mediates the inflammatory response in AAA partially through IL-1α. Fibrosis often accompanies inflammatory AAA 28 and TGF-β1 is a critical molecule involved in the fibrosis development in several diseases, including AAA. 16, 29 In this study, loss of AR suppressed TGF-β1 expression and fibrosis in AAA. Using an in vivo TGF-β1 delivery strategy in GARKO-apoE −/− mice, we found that restoration of TGF-β1 in AR-deficient mice significantly reversed the AAA phenotype, suggesting that AR mediates AAA formation partially through modulating TGF-β1.
The male sex is one of the risk factors for AAA development. On the basis of this epidemiological result, previous studies have evaluated androgen/AR signaling in AAA development via removal of androgen by using castration. Indeed, castration showed promising effects on AAA development in different models of AAA formation, including Ang II induction and elastase challenge. 4, 30 However, castration does not completely block AAA development, implying that other pathways might contribute to AAA formation under castration conditions. Moreover, accumulating evidence has indicated that castration does not completely stop androgen production, and both intracellular and adrenal gland synthesis of androgen have been observed in prostate cancer and embryonic stem cells. 31, 32 Androgen-independent activation of AR has also been demonstrated through phosphorylating AR via different kinds of growth factors, such as epidermal growth factor, insulin-like growth factor 1, and keratinocyte growth factor. 6 A full understanding of AR signaling in AAA formation will be crucial for developing therapeutic approaches especially in males. By using our ARKO mouse models, we explored the importance of AR in AAA progression independently of alternative mechanisms for AR activation, and our results provide important new information as to the significance of targeting AR in patients with AAA.
Actually, androgen/AR signaling in cardiovascular diseases is more complicated than we previously thought. To investigate androgen/AR signaling in cardiovascular diseases, we have generated GARKO mice in different backgrounds including double knockout of AR and low density lipoprotein receptor (LDLR), double knockout of AR and apoE as well as only knockout of AR. All GARKO mice generated in different backgrounds displayed the same appearance as we previously observed.
3 GARKO-LDLR −/− mice had exacerbated atherosclerosis but MARKO-LDLR −/− mice had inhibited atherosclerosis progression. 18 Although we found that macrophage infiltration is one of the potential mechanisms accounting for atherosclerosis progression, this might not be able to explain why GARKO in mice results in exacerbated atherosclerosis progression because GARKO-LDLR −/− mice had some extent of macrophage infiltration inhibition. 33, 34 One explanation for these differential effects of AR on atherosclerosis is lipid metabolism. GARKO-LDLR −/− mice have abnormal lipid profiles because of a dramatic decrease of androgen production. MARKO-LDLR −/− mice have relatively normal lipid profiles without the altered androgen production.
In this study, knockout of AR in the whole body, macrophages, and SMCs would consistently suppress AAA formation. However, knockout of AR in endothelial cells had little impact on AAA development. Our unpublished observations indicate that human umbilical vein endothelial cells have low AR mRNA and undetectable AR protein expression. In addition, immunohistochemistry staining data show almost no AR-positive signal in aortic endothelium ( Figure 6D ), suggesting that AR in endothelial cells might not be critical for AAA development. Although an early study suggested that androgen promotes macrophage adhesion through modulating vascular cell adhesion molecule 1, the study used high androgen concentrations that are not the physiological dose and not seen in mice. 9 This might, in part, explain why knockout of AR in endothelial cells has no effects on AAA development. Regarding AR-mediated molecular mechanism in AAA development, an early study linked androgen/AR signaling and AT1R to AAA development. 4 However, we did not observe a dramatic reduction of AT1R in GARKO mice. In addition, castration results in a substantial reduction of AAA formation in elastase-induced AAA model whose AAA might not be initiated through AT1R, suggesting that androgen/AR signaling might simultaneously affect AAA formation through other molecular pathways. 30 High blood pressure has been suspected to be involved in AAA development. In this study, GARKO-apoE −/− mice actually developed higher blood pressure than WT-apoE −/− mice in Ang II infusion condition. This unexpected result provides the first evidence that high blood pressure in some instances might not be the reason for AAA formation as inhibition of androgen/AR signaling consistently suppresses AAA formation in different AAA animal models. Further studies are needed in order to clarify how AR-mediated blood pressure relates to AAA development.
In clinical observations, males have a 4:1 to 30:1 higher ratio than females for inflammatory AAA incidence, suggesting that androgen/AR signaling might affect AAA development and progression through inflammatory cytokines. Indeed, this study identified that AR would promote IL-1α expression to facilitate AAA progression. In addition, we did observe that several proinflammatory cytokines, including TNF-α, CCL4, CCL9, CCR1, CCR7, integrin αM, and integrin β2, were suppressed in ARKO mice. In our rescue experiments, we showed only partially reversed ARKO effects on AAA development by overexpressing IL-1α. Because ARKO mice have several downregulated inflammatory cytokines, it is possible that other inflammatory cytokines may also be implicated in AR-mediated AAA development as well. Moreover, our previous study has demonstrated that AR transcriptionally regulates TNF-α expression, 34 suggesting the possibility that AR might also enhance AAA development through TNF-α signaling. It is uncertain whether other inflammatory cytokines are transcriptionally modulated by AR. To further clarify these possible molecular regulations, future studies will be needed.
ASC-J9, an AR degradation enhancer, has been shown to suppress AR in different kinds of cells 25 and is effective in treating AR-related diseases, such as prostate cancer. ASC-J9 enhances cutaneous wound healing by inhibiting the inflammatory response. 34 In this study, we demonstrate that ASC-J9 is effective in preventing AAA in a mouse model system. Because the male sex is a strong risk factor for inflammatory AAA, our data support that targeting AR with ASC-J9 has therapeutic potential in treating AAA in humans. In summary, this study clearly demonstrates that AR is required in AAA development, and suggests a novel therapeutic approach to battle AAA via directly targeting the AR.
Perspectives
AAA is a complicated disease and several risk factors have been linked to AAA initiation and progression. The sex difference is one of the risk factors contributing to both atherosclerosis and AAA. Previous studies have demonstrated that knockout of AR in monocytes/macrophages inhibits atherosclerosis in LDLR mutant mouse, but ubiquitous knockout of AR in mouse actually exacerbates atherosclerosis progression. In this study, similar strategies have been used to clarify the role of AR in AAA initiation and progression. Knockout of AR in mice with apoE null background results in complete extinguishment of AAA development. Studies of cell-specific ARKO mice clarified that AR in monocytes/macrophages and SMCs plays a critical role in AAA initiation and progression through IL-1α and TGF-β1 signaling pathways. Unexpectedly, we found that ARKO mice actually developed even higher blood pressure than WT mice. Originally, it has been speculated that hypertension might be the potential cause for AAA initiation. In addition, androgen has been thought and demonstrated to promote blood pressure. However, several observations from the studies of ARKO mice are inconsistent with this hypothesis, and further studies will be needed to determine separate effects of AR on AAA development and blood pressure. 
Animals, cells, and reagents
The lysozyme (Lyz) Cre and transgelin (Tgln) Cre mice were purchased from Jackson laboratory (Bar Harbor, ME). The vascular endothelial cadherin (VECad) Cre and apoE -/-mice were kindly provided by Dr. Jun-Ichi Abe (University of Rochester, NY). All animal studies followed the ''Guide for the Care and Use of Laboratory Animals'' (National Institutes of Health publication). The protocols were reviewed and approved by the University Committee on Animal Resources of University of Rochester. Macrophages, THP-1 cells, were purchased from American Type Culture Collection (Manassas, VA). Primary smooth muscle cells were isolated from C57/B6J mice. Angiotensin II was purchased from EMD-Millipore (Bedford, MA). MicroOsmotic pumps (ALZET 1004) were purchased from ALZET ® (Cupertino, CA). AR, GAPDH, IL1, and TGFβ1 antibodies were purchased from Santa Cruz Biotechnology. pSMAD3, pERK1/2, and ERK1/2 antibodies were purchased from Cell Signaling Biotechnology. MMP9 antibody was from Abcam. F4/80 antibody was purchased from eBioscience. Verhoeff-Van Gieson Staining kit (HT-25A) was purchased from SIGMA.
Generation of general ARKO and tissue specific ARKO mice
The Cre-Lox recombination strategy was used to generate ARKO mice. , and EARKO-apoE -/-mice.
AAA mouse model
For the AAA experiments, all mice were established with apoE-/-background to develop AngII induced AAA formation. Mice at the ages of 12 weeks old were treated with AngII at the dose of 1000 ng/Kg/min via micro-Osmotic pumps. After 28 days, AngII treated mice were monitored for blood pressure with the mouse tail Cuff to confirm that the AngII administration was successful and functional. After sacrifice, the whole abdominal aortas were dissected and denuded to determine the maximal aortic diameter and the AAA incidence. The whole aortic images accompanied with a ruler were taken using Nikon microdissection camera. The images were analyzed for the maximal aortic diameter using Image Pro Plus 5.0 software with serial measurements to determine the maximal aortic diameter. The maximal aortic diameter exceeding 50% of normal aorta was defined as a positive incidence. For ASC-J9 treatment, ASC-J9 (AndroScience, CA) was daily and Intraperitoneally injected into mice with the dose of 50mg ASC-J9/kg mouse body weight. ASC-J9 50mg was dissolved in 50 ul N,N-dimethylacetamide (Sigma-Aldrich), diluted with pre-warmed (55°C) 150ul Cremophor EL (Sigma-Aldrich), and mixed completely until clear yellow color without any uneven yellow color distribution. Finally, the mixed solution was diluted with 800 ul pre-warmed (55°C) saline or 0.9% sterile NaCl, mixed completely as soon as possible, and finished injection within 30 minutes otherwise ASC-J9 would re-crystallize after 30 minutes.
Androgen measurement
Mouse serum was collected for androgen measurement. Basically, mouse was separated one day before sacrificing to prevent dramatic fluctuation of androgen levels. Mouse was sacrificed in another room which is separated from the room having alive mice. Blood was collected by cardiac puncture after mice were killed by CO 2 . Serum was obtained following previous description. Androgens were measured using testosterone ELISA kit (Caymen Chemical) or DHT ELISA kit (BIOTANG) and the assays were performed as the instruction manuals described.
AAA mouse models for IL1 and TGFβ1 experiments
The GARKO-apoE-/-mice were used in these experiments. Lentivirus containing IL1 or TGFβ1 cDNA was generated in HEK-293T cells. Basically, 3 of 10cm dishes were used to produce lentivirus for one mouse injection. pMD2.G, pAX2, and pWPI vector (or pWPI-IL-1 and pWPI-TGF-β1) were transfected to HEK-293T cells using calcium-phosphate precipitation protocol. Lentiviral supernatants were concentrated using Lenti-X TM kit (Clontech Labortories, Inc.) following instruction manual. Lentivirus collected from 3 10-cm culture dishes was purified as pellet. The pellet was diluted with equal amount of matrixgel (Geltrex® LDEV-Free Reduced Growth Factor Basement Membrane Matrix, Life technologies) and saved on ice. Mouse was opened with standard surgical procedure and the aorta was identified. The mixed lentivirus solution (less than 300µL) was injected into the surrounding area of suprarenal aorta. The lentivirus solution became solidifying after injection. Post-operation 3 days, experimental mouse was received another surgery for AngII pump implantation. After another 28 days, mouse was euthanized with CO2 and the aorta was dissected for following experiments.
Immunohistochemical staining
Mouse aorta was dissected and adipose tissues were removed. The area of aorta with AAA was identified, dissected, fixed in 10% neutral buffered formalin, and processed into a paraffin embedded block as previously described 1 . For immunochemistry staining, 5 µm tissue slides were deparaffined, rehydrated, and processed for antigen retrieval with 10 mM Sodium Citrate at pH6.0. The tissue slides were blocked with 5% non-fat milk and 5% BSA for 1 hr, incubated with indicated 1 st antibodies (all prepared with 5% non-fat milk and 5% BSA in PBS) overnight at 4℃, and then incubated with 1:1000 diluted biotinylated secondary antibody (Vector Laboratories, Burlingame, CA) and ABC solution (Vector Laboratories). Tissues were visualized by AEC (DAKO, Carpenteria, CA), followed by Mayor's hematoxylin counterstaining. Stained tissue slides were dehydrated and covered with cover slides. Images were obtained with the microscopic camera and quantified with the image pro plus software.
Chromatin immunoprecipitation assay
Cultured THP-1 (monocyte) cells were treated with 37% formaldehyde to crosslink chromatin with proteins and 1 M glycine was used to stop the reaction. Cell pellets were lysed with SDS lysis buffer and sonicated with sonicator as previously described 2 . The pull down DNA was used to perform PCR reaction. The putative androgen responsive element (ARE) region located in IL1 promoter region is from -514 to -500 (AGAAAATGATTCTCT). The primers used to amplify this region are forward, 5'-GCTACAGCCTCTCCTTTCTTT and reverse, 5'-AGGTATTTGCCTTACACAGAGG. The putative ARE in TGFβ1 promoter region is from -3132 to -3118 (AATACAGCATGTTCT). The primers used to amplify TGFb1 ARE are forward, 5'-TGGACCCTGGGAGGACCTAAATAC and reverse, 5'-GGACAGAGGTGACAGCCAGATTC.
Western blotting
Antibodies used in Western blotting experiments were AR, ERK1/2, PERK1/2, MMP9, GAPDH, TGFβ1, IL1, and IL1R2. Western blotting experiments were performed as previously described 3 . Protein lysates from cells were resolved with 10% sodium dodecyl sulfate-polyacylamide gel electrophoresis (SDS-PAGE) and resolved gels were transferred to PVDF membrane. The proteins located on PVDF membrane were hybridized with listed antibodies and incubated with correlating secondary antibodies conjugated with horseradish peroxidase. After final washing with 0.05 % Tween 20 in PBS, proteins were visualized with ECL kit according to the instruction manual (Pierce ECL Western Blotting Substrate, Thermo Scientific). -tubulin or GAPDH served as loading control.
IL1 ELISA
Mouse blood were collected using cardiac punctuate. Sera were separated using centrifuge. 50 µl serum was used to perform ELISA assay following the instruction manual (ebioscience). The concentration was calculated according to the standard curve.
mRNA extraction and qRTPCR
THP-1 cell mRNA sample was collected by directly adding TRizol to cell pellet. For animal tissue mRNA sample, mouse aorta was dissected and adipose tissues were removed. The only AAA affected area was further dissected and collected with TRizol for mRNA isolation. For mRNA extraction, total RNAs were extracted with TRIzol® (Invitrogen, Grand Island, NY) according to the manufacturer's instructions. One μg mRNA was used to reverse transcribe to cDNA using iScript RT-PCR kit (Bio-Rad, Hercules, CA)). cDNA and specific primers for target genes, and SYBR green master mix (Bio-Rad) were prepared to determine relative gene expressions using an iCycler iQ Multicolor real-time PCR machine (Bio-Rad).
Zymography assay
Cells were seeded in 6-well plates to culture for indicated time periods. To collect the conditioned media (CM) for performing zymography assay, cells were incubated with serum free media for 24 hrs. CM were resolved in 10% SDS-PAGE gel containing 1 mg/ml gelatin. Gels were renatured with renaturing buffer, Triton X-100 in water at 2.5% (v/v), for 30 minutes at room temperature. Gels were then equilibrated with Zymogram Developing Buffer (50 mM Tris base, 0.2 M NaCl, 5 mM CaCl 2 , and 0.02% Brij 35 in d.d.H 2 O) for 30 minutes at room temperature and then overnight at 37C. Gels then were washed with water and stained with the Coomassie Blue R-250 for 30 minutes and images were taken with the Bio-Rad machine.
Promoter construction and luciferase assay
For IL1 promoter construction, the primers used to clone IL1 promoter regions were forward 5'-GGGGTACCCCTACAAAGAGGAGGGAAGAAG-3' and reverse 5'-CGACGCGTCGTCTGTAAGAGAACACCAGTGGC-3'. The IL1 promoter region was ligated to pGL3 luciferase vector. HEK293T cells were used to test promoter transactivation activity via luciferase assay. 0.5 µg pGL3-IL1, 2 ng pRL-TK, and 0.5 µg vector or AR were used to transfect into HEK293T cells with calcium-phosphate precipititation. MMTV, which contains a positive androgen response element served as positive control for AR transactivation assay. After 36 hrs transfection, HEK293T cells were lysed with passive lysis buffer (Promega) and luciferase assay was performed according to instruction manual (Promega).
qRT-PCR array analysis
Mouse aortic tissue was dissected and the AAA disease affected area was used to perform qRT-PCR array analysis. Inflammatory gene array was performed with superarray kit purchased from Qiagen. The suprarenal aortas were collected and denuded. The processed aortas were homogenized in TRIZOL to extract mRNA. mRNA was reverse transcribed to cDNA and prepared cDNA was subjected to qRT-PCR with the superarray kit following the instruction manual. The gene analysis was normalized to housekeeping genes and expressed as relative fold change.
Blood pressure measurement
Mouse blood pressures were measured using non-invasive tail cuff as previously described 4 . Briefly, experimental mice were brought to the equipment room 1 day before measurement, and mice were got used to the environment to minimize the blood pressure variation. All mice were trained 30 minutes before real measurement. 2 set of 30 cycles-measurements were taken to record mice blood pressure.
